News|Articles|December 13, 2023
DEVELOPICK™: High-throughput developability assessment to enable efficient formulation development
Author(s)Samsung Biologics
Explore how Samsung Biologics’ DEVELOPICK™ can help mitigate development risk and identify candidates with the best potential for advancement to IND and beyond
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
What the McKesson-Precision Medicine Deal Signals for Trial Sponsors
2
From Detection to Prediction: Modern Analytical Approaches for Nitrosamine Risk
3
GSK's Jemperli Rectal Cancer Filing Signals Biologics Capacity Shift
4
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
5